APPLICATION
ANDA209201
TYPE
ANDA
ORIGINAL APPROVAL
2018-10-09
LATEST ACTION
2022-01-12
ROUTE
ORAL
DOSAGE FORM
FOR SUSPENSION
MARKETING STATUS
Prescription
Products
AZITHROMYCINPrescription
AZITHROMYCIN EQ 200MG BASE/5ML · FOR SUSPENSION · ORAL
AZITHROMYCINPrescription
AZITHROMYCIN EQ 100MG BASE/5ML · FOR SUSPENSION · ORAL
Approval history
2022-01-12Labeling · Supplement 4 · standardAP
2020-10-18Labeling · Supplement 3 · standardAP
2020-01-23Labeling · Supplement 2 · standardAP
2018-10-09UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.